Cardiovascular Disease Risk 3
Cardiovascular Disease Risk 3
Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.
ЧИТАТЬ ДАЛЕЕ ...
I am happy to offer you a scientific Text on the topic of cardiovascular disease: risk level 3 in English: Cardiovascular disorders: characteristics and Management in high-risk stage 3 Introduction Cardiovascular disease (CVD) is the leading cause of death. The classification into different risk levels allows for a differentiated prevention and therapy. Risk level 3, also known as high risk, which includes people with pre-existing cardiovascular disease or significant risk factors, a significantly increased cardiovascular event risk in the course of 10 years. Definition and criteria for risk level 3 To belong to a risk level of 3 patients who meet at least one of the following criteria: known clinically manifest cardiovascular disease (e.g., coronary heart disease, cerebrovascular disease, peripheral arterial disease); diabetes mellitus with organ involvement (micro‑ or macro-angiopathy) or additional risk factors; severe chronic renal failure (GFR < 30\ \text{ml/min/1{,}73\ m^2}); very elevated levels of individual risk factors (e.g., LDL‑cholesterol ≥5 mmol/l, blood pressure ≥180/110 mmHg); the combined presence of several moderate risk factors, which together result in a high total risk (according to the SCORE risk scale: the overall risk of ≥10% for a fatal cardiovascular event in 10 years). Main Risk Factors The most important modifiable risk factors in high-risk stage 3 are: arterial hypertension; Dyslipidemia (elevated LDL cholesterol, low HDL‑cholesterol); Diabetes mellitus; Smoking; Overweight and obesity; lack of physical activity; unhealthy diet; chronic Stress. Non-modifiable factors include age (men ≥40 years, women ≥50 years of age or postmenopausal), family history of early cardiovascular events, as well as genetic predispositions. Diagnostics A comprehensive diagnosis in patients of the risk level 3 includes: History and physical examination (measurement of blood pressure, BMI calculation, clarification of symptoms). Laboratory tests: lipid spectrum of blood glucose, HbA1c, renal parameters (creatinine, eGFR), urinary analysis. Instrumental: 12‑channel ECG, echocardiography, and possibly Stress ECG or stress echocardiography. In the case of specific suspicion: coronary angiography, CT‑angiography, ultrasound of the Carotids. Therapeutic Strategies The Management of patients in high-risk stage 3 requires a multi-modal treatment: Drug Therapy: Antihypertensives (e.g., ACE inhibitors, AT1 antagonists, beta-blockers, diuretics); Lipid-lowering drugs (statins as a treatment cob, if necessary, ezetimibe, PCSK9 inhibitors); Antidiabetic drugs with cardiovascular Benefits (e.g., SGLT2 inhibitors, GLP‑1 receptor agonists); Platelet aggregation inhibitors (e.g., acetylsalicylic acid) in the case of indication; if necessary, additional drugs for symptom control (nitrates, antiarrhythmics). Lifestyle changes: Smoking cessation; healthy diet (DASH diet, Mediterranean diet); regular physical activity (at least 150 minutes of moderate load per week); Weight reduction in obesity (goal: BMI <25 kg/m 2 ); Stress management and adequate sleep. Regular Follow-Up: Blood pressure control; Monitoring of blood fats and blood sugar levels; Adjustment of the medication after the course and side effects; Training and Motivation of the patient (cardiac rehabilitation programs). Conclusion Patients with cardiovascular risk level 3 require an intensive, individualized and multidisciplinary care. Through the combined application of evidence-based medications and sustainable lifestyle changes in the risk for cardiovascular events is significantly lower, and the quality of life and life expectancy improve. Early identification and targeted Intervention for those in this high-risk group constitutes a key to the reduction of cardiovascular morbidity and mortality. If you wish, I can make certain sections in more detail, or other aspects add!
Cardio Balance helps reduce blood fat levels by reducing the production of cholesterol and triglycerides in the body and improving the transportation of fats in the bloodstream. Cardiovascular Disease Risk 3. Cardio Balance is an all-natural formula designed to act on the root cause of high blood pressure and fatal cardiovascular diseases and strokes. It's a zero-risk range for men and women of all ages. The natural ingredients-rich nutrient profile helps reduce blood cholesterol levels and boost blood circulation function, digestive system, and overall health.
Diseases of the cardiovascular system of dogs
Preventive Measures For Cardiovascular Diseases
Center for risk management of cardiovascular diseases
Prayer of hypertension for men
http://h25525tb.beget.tech/posts/33149-prevention-of-cardiovascular-diseases-animals.html
http://derelc82.beget.tech/posts/3385-medications-for-hypertension-with-a-diuretic-effect.html
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.